International Journal of Urology

Papers
(The H4-Index of International Journal of Urology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
59
A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients47
Editorial Comment to Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study35
Risk factors and timing of complication presentation following primary hypospadias repair in adolescents27
Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk‐based strategy in 1362 consecutive patients25
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study24
Current Evidence on Cabazitaxel for Prostate Cancer Therapy: A Narrative Review23
Intra‐ and post‐operative management of pancreatic injury during laparoscopic nephrectomy20
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non‐muscle invasive bladder cancer: A multi‐institutional collaborative study18
Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy18
Trends of radical cystectomy and comparisons of surgical outcomes among surgical approaches focusing on robot‐assisted radical cystectomy: A Japanese nationwide database study18
Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, for lower urinary tract dysfunction in mice with spinal cord injury17
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability17
Sarcopenia as a predictor of mortality in kidney transplant recipients: A 5‐year prospective cohort study with propensity score matching17
This issue 31‐1017
Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer17
Patterns of recurrence in genuine and induced oligometastatic castration‐resistant prostate cancer treated with progressive site‐directed therapy16
0.17483901977539